The association of serum magnesium and mortality outcomes in heart failure patients
Open Access
- 1 December 2016
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Medicine
- Vol. 95 (50), e5406
- https://doi.org/10.1097/md.0000000000005406
Abstract
Background: Low serum magnesium (Mg) has been independently shown to increase risk of heart failure (HF), but data on the association between serum Mg concentration and the outcome of patients with HF are conflicting. The purpose of this systematic review and meta-analysis was to estimate the prognostic effects of hypermagnesemia and hypomagnesemia on cardiovascular (CV) mortality and all-cause mortality (ACM) of patients with HF. Methods: Relevant studies were identified from Medline and Scopus databases. Included and excluded criteria were defined. Effects (i.e., log [risk ratio [RR]]) of hypomagnesemia and hypermagnesemia versus normomagnesemia were estimated using Poisson regression, and then a multivariate meta-analysis was applied for pooling RRs across studies. Heterogeneity was explored using a meta-regression and subgroup analysis. Results: On analysis, 7 eligible prospective studies yielded a total of 5172 chronic HF patients with 913 and 1438 deaths from CV and ACM, respectively. Most participants were elderly men with left ventricular (LV) ejection fraction <= 40%. Those patients with baseline hypermagnesemia had a significantly higher risk of CV mortality (RR, 1.38; 95% confidence interval [CI], 1.07-1.78) or ACM (RR, 1.35; 95% CI, 1.18-1.54) than those with baseline normomagnesemia. However, baseline hypomagnesemia was not associated with the risk of CV mortality (RR, 1.11; 95% CI, 0.79-1.57) and ACM (RR, 1.11; 95% CI, 0.87-1.41). A subgroup analysis by Mg cutoff suggested a dose-response trend for hypermagnesemia effects, that is, the pooled RRs for CV mortality were 1.28 (95% CI, 1.05-1.55) and 1.92 (95% CI, 1.00-3.68) for the cutoff of 0.89 to 1.00 and 1.05 to 1.70 mmol/L, respectively. Conclusion: The present systematic review and meta-analysis suggested that, in HF patients, hypermagnesemia with serum Mg >= 1.05mmol/L was associated with an increased risk of CV mortality and ACM but this was not observed for hypomagnesemia. This finding was limited to the elderly patients with chronic HF who had reduced LV systolic function.Keywords
This publication has 41 references indexed in Scilit:
- Forecasting the Impact of Heart Failure in the United StatesCirculation: Heart Failure, 2013
- ß-Adrenergic Stimulation Increases RyR2 Activity via Intracellular Ca2+ and Mg2+ RegulationPLOS ONE, 2013
- Magnesium and the Risk of Cardiovascular Events: A Meta-Analysis of Prospective Cohort StudiesPLOS ONE, 2013
- Cost-Effectiveness of N-Terminal Pro-B-Type Natriuretic-Guided Therapy in Elderly Heart Failure Patients: Results From TIME-CHF (Trial of Intensified versus Standard Medical Therapy in Elderly Patients with Congestive Heart Failure)JACC: Heart Failure, 2013
- Magnesium and outcomes in patients with chronic kidney disease: focus on vascular calcification, atherosclerosis and survivalClinical Kidney Journal, 2012
- Low serum magnesium and cardiovascular mortality in chronic heart failure: A propensity-matched studyInternational Journal of Cardiology, 2009
- Heart Failure Incidence and Survival (from the Atherosclerosis Risk in Communities Study)The American Journal of Cardiology, 2008
- Practical methods for incorporating summary time-to-event data into meta-analysisTrials, 2007
- Predictors of sudden death and death from pump failure in congestive heart failure are different. Analysis of 24 h Holter monitoring, clinical variables, blood chemistry, exercise test and radionuclide angiographyInternational Journal of Cardiology, 1997
- Significance of magnesium in congestive heart failureAmerican Heart Journal, 1996